ITP RevBio Receives FDA approval for a first in-human Clinical Trial!•ITP PI, Dr. Isabelle Lombaert wins the 2023 University of Michigan Medical School’s Frankel Innovation Initiative Award!•RevBio Awarded a $3.4 Million NIH Grant•Congratulations to our ITP teams presenting at Forsyth dentech 2023!•SAVE THE DATE! 2024 MPWRM Resource Center Stakeholder's Summit - April 8-9, 2024•SAVE THE DATE! 2023 DOCTRC Retreat - December 4-6, 2023 in Los Angeles, CA•MPWRM Resource Center and DOCTRC were highlighted in the keynote talk at NIDCR's 75th anniversary event, NIDCR at 75: Celebrating the Past, Charting the Future•RevBio Receives ISO 13485 Certification for its Quality Management System!•GreenMark Biomedical Launches CrystLCare™ Biorestorative, Fluoride-Free!•GreenMark Biomedical's LumiCare Carries Detection Rinse makes the cover of Dental Products Report!

2022 4th ANNUAL STAKEHOLDER’S SUMMIT

April 18-19, 2022

Virtual Meeting

As a follow-on to December 2021 DOCTRC session on Critical Considerations in Preclinical Product Development, this year’s Annual Stakeholder’s Summit focused on building a compelling pitch deck.  Day 1 included updates from the Resource Center and presentations by the ITP teams, and day 2 comprised of 2 keynote talks and mini-sessions on components of a compelling pitch deck, followed by a breakout discussion.  Event agenda can be found here and the recordings of the sessions can be found below.

Thank you to all those in attendance.  Our next event will be the joint DOCTRC retreat on Oct 31 – Nov 2, 2022.  Please save the dates.  Additional information will be forthcoming as the dates approach.

Welcome Remarks

Lillian Shum |Director, Division of Extramural Research |NIH NIDCR

Attracting and Preparing for Investor Meetings

Gene Dorff | Chief Executive Officer | Solmetex, LLC

&

Successful Fundraising Presenations and Strategies: Point to Consider

Marty Dymek |CEO | Navigate Surgical Technologies USA, Inc.

Considerations in Preclinical Product Development, II: Building a Compelling Pitch Deck

Session 1: Regulatory Strategies | Kay Fuller (MRDS LLC)

ITP Panel: Emergence Dental/nanoMag, Dr. Bertassoni/Dr. Yelick

Session 2: Market Assessment | Francine Berkey (The Avenues Company)

ITP Panel: Dr. Giannobile, Dr. Taboas/Dr. Ray

Session 3: User Handling Trials | Jeanne Ambruster (The Avenues Company)

ITP Panel: Ostiio, RevBio

INTERDISCIPLINARY TRANSLATIONAL PROJECTS PROGRAM

LEARN MORE